Positive News SentimentPositive NewsNASDAQ:MLAB Mesa Laboratories (MLAB) Stock Price, News & Analysis $63.60 +1.95 (+3.15%) As of 10:26 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Mesa Laboratories Stock (NASDAQ:MLAB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Mesa Laboratories alerts:Sign Up Key Stats Today's Range$61.42▼$64.6650-Day Range$57.44▼$92.9452-Week Range$55.45▼$155.12Volume42,703 shsAverage Volume88,812 shsMarket Capitalization$349.82 millionP/E RatioN/ADividend Yield1.01%Price Target$113.50Consensus RatingHold Company Overview Mesa Laboratories, Inc. (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes. The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications. Mesa Laboratories also offers calibration standards, software platforms and technical support services that enable clients to maintain accurate instrument performance and fulfill industry-specific quality assurance requirements. Since its founding in 1968, Mesa Laboratories has expanded through a combination of in-house research and development and strategic acquisitions to broaden its instrumentation offerings and geographic reach. The company maintains manufacturing and service facilities across North America, Europe and the Asia-Pacific region, leveraging a global distribution network to deliver products and support to customers in more than 100 countries.AI Generated. May Contain Errors. Read More Mesa Laboratories Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks67th Percentile Overall ScoreMLAB MarketRank™: Mesa Laboratories scored higher than 67% of companies evaluated by MarketBeat, and ranked 331st out of 954 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingMesa Laboratories has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Upside PotentialMesa Laboratories has a consensus price target of $113.50, representing about 84.1% upside from its current price of $61.66.Amount of Analyst CoverageMesa Laboratories has only been the subject of 2 research reports in the past 90 days.Read more about Mesa Laboratories' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth9.00% Earnings GrowthEarnings for Mesa Laboratories are expected to grow by 9.00% in the coming year, from $8.00 to $8.72 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Mesa Laboratories is -440.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Mesa Laboratories is -440.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMesa Laboratories has a P/B Ratio of 2.10. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Mesa Laboratories' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.63% of the float of Mesa Laboratories has been sold short.Short Interest Ratio / Days to CoverMesa Laboratories has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Mesa Laboratories has recently increased by 0.15%, indicating that investor sentiment is decreasing. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldMesa Laboratories pays a meaningful dividend of 1.04%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthMesa Laboratories does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Mesa Laboratories will have a dividend payout ratio of 7.34% next year. This indicates that Mesa Laboratories will be able to sustain or increase its dividend.Read more about Mesa Laboratories' dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted7.63% of the float of Mesa Laboratories has been sold short.Short Interest Ratio / Days to CoverMesa Laboratories has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Mesa Laboratories has recently increased by 0.15%, indicating that investor sentiment is decreasing. News and Social Media2.7 / 5News Sentiment1.84 News SentimentMesa Laboratories has a news sentiment score of 1.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.94 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Mesa Laboratories this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 1 people have added Mesa Laboratories to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Mesa Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $296,507.00 in company stock.Percentage Held by InsidersOnly 4.90% of the stock of Mesa Laboratories is held by insiders.Percentage Held by Institutions90.60% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Mesa Laboratories' insider trading history. Receive MLAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MLAB Stock News HeadlinesMesa Laboratories Holds Annual Shareholder MeetingAugust 25, 2025 | tipranks.comIt Might Not Be A Great Idea To Buy Mesa Laboratories, Inc. (NASDAQ:MLAB) For Its Next DividendAugust 24, 2025 | finance.yahoo.comReagan’s former tech advisor sharing bombshell announcementGeorge Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the last 40 years. Now he's stepping forward with an even bigger prediction about what's being built in the Arizona desert. He believes 3 little-known companies will explode when a bombshell announcement just days from now. Smart investors are already positioning themselves.September 15 at 2:00 AM | Banyan Hill Publishing (Ad)Mesa Laboratories (NASDAQ:MLAB) Has Announced A Dividend Of $0.16August 20, 2025 | finance.yahoo.comMesa Laboratories, Inc.: Mesa Laboratories Executes Previously-Announced Strategic Financing PlanAugust 19, 2025 | finanznachrichten.deMesa Laboratories Executes Previously-Announced Strategic Financing PlanAugust 18, 2025 | gurufocus.comMesa Laboratories Executes Previously-Announced Strategic Financing PlanAugust 18, 2025 | markets.businessinsider.comMesa Laboratories Draws $97M for Convertible Notes SettlementAugust 18, 2025 | tipranks.comSee More Headlines MLAB Stock Analysis - Frequently Asked Questions How have MLAB shares performed this year? Mesa Laboratories' stock was trading at $131.87 on January 1st, 2025. Since then, MLAB stock has decreased by 53.2% and is now trading at $61.66. How were Mesa Laboratories' earnings last quarter? Mesa Laboratories, Inc. (NASDAQ:MLAB) released its earnings results on Tuesday, February, 4th. The medical instruments supplier reported $2.07 EPS for the quarter, beating the consensus estimate of $1.41 by $0.66. Mesa Laboratories had a negative net margin of 0.26% and a positive trailing twelve-month return on equity of 24.49%. Who are Mesa Laboratories' major shareholders? Mesa Laboratories' top institutional investors include Conestoga Capital Advisors LLC (10.29%), Ranger Investment Management L.P. (3.89%), Geneva Capital Management LLC (3.62%) and Raymond James Financial Inc. (3.37%). Insiders that own company stock include John Bradley Schmieder, Gary M Owens, John Sakys, Shannon Hall and Brian David Archbold. View institutional ownership trends. How do I buy shares of Mesa Laboratories? Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Mesa Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Mesa Laboratories investors own include American Water Works (AWK), Waste Connections (WCN), AU Optronics (AUOTY), DiamondRock Hospitality (DRH), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings2/04/2025Record date for 9/15 Dividend8/29/2025Ex-Dividend for 9/15 Dividend8/29/2025Today9/15/2025Dividend Payable9/15/2025Next Earnings (Estimated)11/06/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryElectronic Equipment & Instruments Current SymbolNASDAQ:MLAB CIK724004 Webwww.mesalabs.com Phone(303) 987-8000Fax303-987-8989Employees680Year Founded1982Price Target and Rating Average Price Target for Mesa Laboratories$113.50 High Price Target$160.00 Low Price Target$67.00 Potential Upside/Downside+84.1%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($0.14) Trailing P/E RatioN/A Forward P/E Ratio7.71 P/E GrowthN/ANet Income-$1.97 million Net Margins-0.26% Pretax Margin3.74% Return on Equity24.49% Return on Assets9.03% Debt Debt-to-Equity Ratio0.46 Current Ratio0.66 Quick Ratio0.47 Sales & Book Value Annual Sales$240.98 million Price / Sales1.41 Cash Flow$12.26 per share Price / Cash Flow5.03 Book Value$29.42 per share Price / Book2.10Miscellaneous Outstanding Shares5,500,000Free Float5,232,000Market Cap$339.13 million OptionableNot Optionable Beta0.82 Social Links These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:MLAB) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesa Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesa Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MLAB Stock Alerts